Close filters
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
from to

Products from peptides&elephants GmbH

Filter
No results were found for the filter!
NEW
BA.5 Omicron full length SCoV2 (Spike Glycoprotein) BA.5 Omicron full length SCoV2 (Spike...
This peptide pool covers the whole spike glycoprotein with all mutations of the new omicron variant BA.5 of SARS-CoV-2 (315 peptides, delivered in two subpools of 158 & 157 peptides) .
€805.00 *
NEW
Kappa Variant B.1.617.1 SCoV2 (Spike Glycoprotein) Kappa Variant B.1.617.1 SCoV2 (Spike Glycoprotein)
This peptide pool with 25 peptides covers all mutations in the Spike Glycoprotein derived from the kappa variant B.1.617.1 of SARS-CoV-2 which emerged in India in October 2020.
€230.00 *
NEW
HHV6 (U90) Peptide Pool HHV6 (U90) Peptide Pool
Pool of 267 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein U90 (UniProt ID: Q77PU6) of Human herpesvirus 6B for T cell assays (antigen specific T-cell stimulation).
€258.75 *
NEW
RSVA Peptide Pool RSVA Peptide Pool
Pool of 72 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Major surface glycoprotein G (UniProt ID: P03423) of Human respiratory syncytial virus A (strain A2)
€172.50 *
NEW
HPV16 E7 HPV16 E7
Pool of 22 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein E7 (Swiss-Prot ID: P03129) of Human papillomavirus.
€172.50 *
NEW
HPV16 E6 HPV16 E6
Pool of 37 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein E6 (Swiss-Prot ID: P03126) of Human papillomavirus.
€172.50 *
NEW
HPV16 (L1) HPV16 (L1)
Pool of 124 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein L1 (Swiss-Prot ID: Q9WLQ6) of Human papillomavirus - type 16
€291.00 *
NEW
HPV16 (L2) HPV16 (L2)
Pool of 116 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein L2 (Swiss-Prot ID: P03107) of Human papillomavirus - type 16.
€291.00 *
NEW
HPV18 (L2) HPV18 (L2)
Pool of 113 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein L2 (Swiss-Prot ID: P06793) of Human papillomavirus.
€291.00 *
NEW
HPV18 (L1) HPV18 (L1)
Pool of 140 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein L1 (Swiss-Prot ID: P06794) of Human papillomavirus - type 18.
€291.00 *
HCMVA (IE1) Peptide Pool HCMVA (IE1) Peptide Pool
Pool of 120 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through 55 kDa immediate-early protein 1 (IE-1) (UniProt ID: P13202) of Human cytomegalovirus (HHV-5) frequently used as positive control
€218.50 *
p53 (Y220C)
From €57.50 *
Details
Omicron Variant B.1.1.529 SCoV2 wt (Spike Glycoprotein) Omicron Variant B.1.1.529 SCoV2 wt (Spike...
This pool consists of 82 peptides of the spike protein and represent the wildtype peptides to the mutations of the new omicron variant of SARS-CoV-2 (B.1.1.529) and is therefore recommended as a reference.
€230.00 *
Delta Variant B.1.617.2 SCoV2 wt (Spike Glycoprotein) Delta Variant B.1.617.2 SCoV2 wt (Spike...
This pool consists of 27 peptides of the spike protein and represent the wildtype peptides to the mutations of the delta variant of SARS-CoV-2 (B.1.617.2) and is therefore recommended as a reference.
€230.00 *
Omicron Variant B.1.1.529 SCoV2 (Spike Glycoprotein) Omicron Variant B.1.1.529 SCoV2 (Spike...
This peptide pool with 80 peptides covers all mutations in the Spike Glycoprotein derived from the omicron variant B.1.1.529 of SARS-CoV-2 which is prevalent in south africa.
€230.00 *
Omicron full length B.1.1.529 SCoV2 (Spike Glycoprotein) Omicron full length B.1.1.529 SCoV2 (Spike...
This peptide pool covers the whole spike glycoprotein with all mutations of the new omicron variant of SARS-CoV-2 (315 peptides, delivered in two subpools of 158 & 157 peptides) .
€805.00 *
Trp2 180-188
This peptide is derived from tyrosinase-related protein 2 (TRP-2) residues 180-188. TRP-2 peptide, also named L-dopachrome tautomerase, H-2KB or DCT, belongs to the melanocyte differentiation antigens and has been implicated as a target...
From €57.50 *
Details
[Phe17] - Apelin
Apelin has been found to be expressed in the spinal cord and the human brain and when performing immunohistochemistry it was observed that apelin-17 is significantly expressed in the human heart, brain, lungs and endothelial cells.
From €115.00 *
Details
SARS-CoV-2 Surface GP A2 1000-1008 (HLA-A*02:01)
RLQSLQTYV is an antigen-specific SARS-CoV-2 peptide
From €92.00 *
Details
[beta]-Casomorphin (1-7), bovine
#
From €57.50 *
Details
Influenza A virus HA 306-318 (DRB1*01:01)
Antigen Peptide Influenza PKYVKQNTLKLAT for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays
From €92.00 *
Details
Human PRAME 254-262 (HLA-A24)
#
From €57.50 *
Details
Human PRAME 254-262 (HLA-A24)-Copy
#
€115.00 *
Details
HEL 11-25
#
From €115.00 *
Details
ACTH (1-39) (human)
ACTH (1-39), human is a synthetic peptide corresponding to the first 39 amino acids of human ACTH/adrenocorticotropin which is the major regulator of adrenal cortex function. ACTH stimulates the synthesis of steroidal hormones.
From €241.50 *
Details
ACTH (18-39) (human)
Adrenocorticotropic hormone (ACTH) (18-39) is a C-terminal peptide fragment of ACTH, a peptide hormone found in the brain that is involved in the biological stress response. ACTH is produced in the anterior pituitary gland upon...
From €172.50 *
Details
Iota Variant B.1.526 SCoV2 (Spike Glycoprotein) Iota Variant B.1.526 SCoV2 (Spike Glycoprotein)
This peptide pool with 21 peptides covers all mutations in the Spike Glycoprotein derived from the iota variant B.1.526 of SARS-CoV-2 which emerged in the US in November 2020.
€230.00 *
Lambda Variant C.37 SCoV2 (Spike Glycoprotein) Lambda Variant C.37 SCoV2 (Spike Glycoprotein)
This peptide pool with 25 peptides covers all mutations in the Spike Glycoprotein derived from the lambda variant C.37 of SARS-CoV-2 which emerged in Peru in August 2020.
€230.00 *
RSV Sub Peptide Pool (>95% HPLC) RSV Sub Peptide Pool (>95% HPLC)
This pool consists of 28 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from Respiratory Syncytial Virus (RSV).
€63.25 *
CMV Sub Peptide Pool (>95% HPLC) CMV Sub Peptide Pool (>95% HPLC)
This pool consists of 14 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from cytomegalovirus (CMV).
€63.25 *
Proinsulin 90-104
This is a Proinsulin-derived peptide of GIVEQCCTSICSLYQ sequence covering 90-104 and DRB1*04:01 molecule.
From €115.00 *
Details
HBV Sub Peptide Pool (>95% HPLC) HBV Sub Peptide Pool (>95% HPLC)
This pool consists of 9 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from Hepatitis B virus (HBV).
€63.25 *
EBV LMP-2 340-349 mutant (HLA-A*11:01) 348T
SSCSSCPLTK is a linear mutated peptidic epitope (epitope ID60930) studied as part of Latent membrane protein 2 from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays...
From €57.50 *
Details
Gamma Variant P.1 SCoV2 (Spike Glycoprotein) Gamma Variant P.1 SCoV2 (Spike Glycoprotein)
This peptide pool with 36 peptides covers all mutations in the Spike Glycoprotein derived from the gamma variant P.1 of SARS-CoV-2 which emerged in Brazil in late 2020 and has similar mutations to the beta variant B.1.351.
€230.00 *
Beta Variant B.1.351 SCoV2 (Spike Glycoprotein) Beta Variant B.1.351 SCoV2 (Spike Glycoprotein)
This peptide pool with 34 peptides covers all mutations in the Spike Glycoprotein derived from the beta variant B.1.351 of SARS-CoV-2 which emerged in South Africa in December 2020 and reduces the effectiveness of some vaccines.
€230.00 *
Delta Variant B.1.617.2 SCoV2 (Spike Glycoprotein) Delta Variant B.1.617.2 SCoV2 (Spike Glycoprotein)
This peptide pool with 27 peptides covers all mutations in the Spike Glycoprotein derived from the delta variant B.1.617.2 of SARS-CoV-2 which is prevalent in India and carries the L452R spike mutation, among others.
€230.00 *
Alpha Variant B.1.1.7 SCoV2 (Spike Glycoprotein) Alpha Variant B.1.1.7 SCoV2 (Spike Glycoprotein)
This peptide pool with 31 peptides covers all mutations in the Spike Glycoprotein derived from the alpha variant B.1.1.7 of SARS-CoV-2 which emerged in Britain in December 2020 and is thought to be roughly 50 percent more infectious and...
€230.00 *
RSV Fusion protein 540-548 (HLA-A*02:01)
#
From €57.50 *
Details
HIV Env 586-593 (HLA-B*08:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed Env-derived peptide of YLKDQQLL sequence covering 586-593 and...
From €57.50 *
Details
HIV env 816-825 (HLA-A*02:01)
Correlation between HLA class I and spontaneous control of HIV-1 was significant for 7-8 epitopes when 341 chronic, HIV-infected subjects, divided into controllers and non-controllers, were tested for EliSpot responses to 257 optimally...
From €57.50 *
Details
LCMV envelope gp 10-18 (HLA-A*02:01)
ALPHIIDEV is a linear peptidic epitope (epitope ID2814) studied as part of Pre-glycoprotein polyprotein GP complex from Lymphocytic choriomeningitis mammarenavirus. This epitope has been studied for immune reactivity, tested in T cell...
From €57.50 *
Details
gp100 170-178 (HLA-A*24:02)
#
From €57.50 *
Details
EBV EBNA-1 407-417 mutant (HLA-B*35:08) 411D
EBV EBNA1-derived peptide of HPVGDADYFEY covering 407-417 and B*35:08 molecule. HPVGDADYFEY is a linear peptidic epitope (epitope ID 24525) studied as part of Epstein-Barr nuclear antigen 1 from Human herpesvirus 4 (Epstein Barr virus)....
From €92.00 *
Details
EBV EBNA-1 407-417 mutant (HLA-B*35:01) 410A
EBNA1-derived peptide of HPVAEADYFEY covering 407-417 and B*35:08 molecule. HPVAEADYFEY is a linear peptidic epitope (epitope ID 227777) studied as part of Epstein-Barr nuclear antigen 1 from Human herpesvirus 4 (Epstein Barr virus)....
From €92.00 *
Details
MBP (63–81)
#
From €149.50 *
Details
MOG 94 - 110, human
Myelin oligodendrocyte glycoprotein (MOG)94 - 110, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €195.50 *
Details
MOG 40-55
Myelin oligodendrocyte glycoprotein (MOG) 40-55, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
MOG 40-54
Myelin oligodendrocyte glycoprotein (MOG) 40-54, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
MBP (54-72) human
MBP (54-72) human - SHHAARTTHYGSLPQKSQR represents a short peptide sequence of the protein lipid part of the myelin sheath. Such proteins are obviously targets of the immune defense in multiple sclerosis.
From €195.50 *
Details
MOG 97-108
Myelin oligodendrocyte glycoprotein (MOG)97 - 108, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
FLAG
This epitope tag is a short hydrophilic, highly charged peptide. It is the most widely used epitope tag employed in structural and functional studies of proteins.
From €92.00 *
Details
RSV MP 229-237 (HLA-A*01:01)
#
From €57.50 *
Details
gp100 17-25 (HLA-A*03:01)
#
From €57.50 *
Details
Epsilon Variant B.1.427/B.1.429 SCoV2 (Spike Glycoprotein) Epsilon Variant B.1.427/B.1.429 SCoV2 (Spike...
This peptide pool with 14 peptides covers all mutations in the Spike Glycoprotein derived from the epsilon variant B.1.427/B.1.429 of SARS-CoV-2 which emerged in the US in March 2020.
€230.00 *
Zeta Variant P.2 SCoV2 (Spike Glycoprotein) Zeta Variant P.2 SCoV2 (Spike Glycoprotein)
This peptide pool with 12 peptides covers all mutations in the Spike Glycoprotein derived from the zeta variant P.2 of SARS-CoV-2 which emerged in Brazil in April 2020.
€230.00 *
Eta Variant B.1.525 SCoV2 (Spike Glycoprotein) Eta Variant B.1.525 SCoV2 (Spike Glycoprotein)
This peptide pool with 31 peptides covers all mutations in the Spike Glycoprotein derived from the eta variant B.1.525 of SARS-CoV-2 which emerged in Angola in December 2020.
€230.00 *
Theta Variant P.3 SCoV2 (Spike Glycoprotein) Theta Variant P.3 SCoV2 (Spike Glycoprotein)
This peptide pool with 30 peptides covers all mutations in the Spike Glycoprotein derived from the theta variant P.3 of SARS-CoV-2 which emerged in the Philippines in January 2021.
€230.00 *
EBV (EBNA-3b) Peptide Pool EBV (EBNA-3b) Peptide Pool
Pool of 234 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Epstein-Barr nuclear antigen 4 (EBNA3b) (UniProt ID: Q1HVG4) of Epstein-Barr virus (HHV4) for T cell assays.
€218.50 *
Influenza A (H1N1) HA Influenza A (H1N1) HA
Pool of 139 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Hemagglutinin (UniProt ID: C3W5S1) of Influenza A virus (strain swl A/California/04/2009 H1N1)
€230.00 *
MBP (1-11) human
MBP (1-11) human - ASQKRPSQRHG represents a short peptide sequence of the protein lipid part of the myelin sheath. Such proteins are obviously targets of the immune defense in multiple sclerosis.
From €57.50 *
Details
Influenza A NP 366-374 (H-2 Db)
This peptide is a tetramer of biotinylated peptide with streptavidin mainly composed of Influenza-derived peptide of ASNENMETM sequence covering 366-374 and H-2Db molecule. The pMHC tetramer recognizes mouse CD8 T cells, and can be used...
From €57.50 *
Details
HHV8 (K8.1) Peptide Pool HHV8 (K8.1) Peptide Pool
Pool of 55 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Glycoprotein gp35/37 (UniProt ID: O36551) of Human herpesvirus 8 (HHV-8) (Kaposi's sarcoma-associated herpesvirus) for T cell assays (antigen...
€201.25 *
LLO 216–227 (H2-Kd)
#
From €92.00 *
Details
LLO 189-200 (H2-Kd )
#
From €92.00 *
Details
p60 449–457 (H-2Kd)
#
From €57.50 *
Details
p60 476 - 484 (H-2Kd)
#
From €57.50 *
Details
P60 217-225 (H-2Kd)
#
From €57.50 *
Details
PRAME 242-251 (HLA-A*3)
#
From €57.50 *
Details
EBV LMP-2 340-349 mutant (HLA-A*11:01) 348T
#
From €57.50 *
Details
HIV p24 gag 176-184 mutant (HLA-B*53:01) 183G
#
From €57.50 *
Details
SARS-CoV-2 Surface GP_1 B7 (HLA-B*07:02)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Nucleocapsid_3 B7 (HLA-B*07:02)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Nucleocapsid_2 B7 (HLA-B*07:02)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Nucleocapsid_1 B7 (HLA-B*07:02)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP_3 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 ORF6 prot_1 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 ORF3a prot_2 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 ORF3a prot_1 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Membrane GP_2 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Membrane GP_1 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP_1 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV Nucleocapsid A2 316-324 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV Nucleocapsid A2 316-324 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Nucleocapsid A2 N223-231 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV Nucleocapsid A2 226-234 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV Nucleocapsid A2 219-227 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV Nucleocapsid A2 138-146 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Membrane GP A2 89-97 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Membrane GP A2 61-70 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP A2 1220–1228 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP A2 1192–1200 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP A2 978–986 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP_2 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP A2 958–966 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP A2 691–699 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP A2 424–433 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV SSp-1 A2 (HLA-A*02:01)
The sequence is related to the HLA-A*0201-restricted coronavirus SARS-CoV spike protein peptide SSp-1. It was demonstrated that SARS-CoV protein-derived peptide-1 (SSp-1 RLNEVAKNL) induces peptide-specific CTLs both in vivo (transgenic...
From €92.00 *
Details
DEAD box RNA helicase 355–363 (HLA-C*05:01)
#
From €57.50 *
Details
Rev 67-75 mutant (HLA-C*05:01) 75L
#
From €57.50 *
Details
GAD65 113-132 (DRB1*04:01)
#
From €195.50 *
Details
GAD65 274-286 (DRB1*04:01)
#
From €149.50 *
Details
GAD65 555-567 (DRB1*04:01)
#
From €149.50 *
Details
fn20 env 122-141
#
From €195.50 *
Details
SNTB2 351-360
VTEKDLLLY is a linear peptidic epitope studied as part of Beta-2-syntrophin from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in MHC ligand assays.
From €57.50 *
Details
HPV E6 31-38
HDIILECV is a linear peptidic epitope studied as part of Protein E6 from Alphapapillomavirus 9, tested in T cell assays.
From €57.50 *
Details
HPV E7 88-97 (HLA-A*11)
GIVCPICSQK is a linear peptidic epitope studied as part of Protein E7 from Alphapapillomavirus 9. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays.
From €57.50 *
Details
HPV E6 133–142
HNIRGRWTGR is a linear peptidic epitope studied as part of Protein E6 from Alphapapillomavirus 9, tested in T cell assays.
From €57.50 *
Details
IE62 593-601 (HLA-A*02:01)
ALWALPHAA is a linear peptidic epitope studied as part of Major viral transcription factor ICP4 homolog from Human herpesvirus 3 (Varicella-zoster virus). This epitope has been studied for immune reactivity, tested in T cell assays.
From €57.50 *
Details
LCMV GP 118-125
ISHNFCNL is a linear peptidic epitope studied as part of Pre-glycoprotein polyprotein GP complex from Lymphocytic choriomeningitis mammarenavirus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC...
From €57.50 *
Details
LCMV NP 205-212
YTVKYPNL is a linear peptidic epitope studied as part of Nucleoprotein from Lymphocytic choriomeningitis mammarenavirus, Nucleoprotein from Guanarito mammarenavirus, Nucleoprotein from Machupo mammarenavirus and Argentinian...
From €57.50 *
Details
LCMV NP 201-215
LGLLYTVKYPNLNDL is a linear peptidic epitope studied as part of Nucleoprotein from Lymphocytic choriomeningitis mammarenavirus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays.
From €115.00 *
Details
LCMV NP 309-328
SGEGWPYIACRTSIVGRAWE is a linear peptidic epitope studied as part of Nucleoprotein from Lymphocytic choriomeningitis mammarenavirus. This epitope has been studied for immune reactivity, tested in T cell assays and B cell assays.
From €195.50 *
Details
TRP1 113-126 Mouse Tyrp2/gp75
CRPGWRGAACNQKI is a linear peptide tested in T cell assays and MHC ligand assay.
From €115.00 *
Details
EBV EBNA-1 72-80 (HLA-B*35:01)
RPQKRPSCI is a linear peptidic epitope studied as part of Epstein-Barr nuclear antigen 1 from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays.
From €57.50 *
Details
HCV NS3 1267-1275
LGFGAYMSK is a linear peptidic epitope studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been tested in T cell assays and MHC ligand assays.
From €57.50 *
Details
HDV 46-54
DENPWLGNI is a linear peptidic epitope studied as part of Large delta antigen from Hepatitis delta virus, this epitope has been tested in T cell assays and MHC ligand assays.
From €57.50 *
Details
CPIM 399–406 (H-2 Kb)
#
From €57.50 *
Details
SUMO2 57-66
#
From €57.50 *
Details
SUMO1 57-67
#
From €57.50 *
Details
HNRNPA1 339-348 (HLA C*07:02)
GPYGGGGQYF is a linear peptidic epitope studied as part of Heterogeneous nuclear ribonucleoprotein A1-like 2 from Homo sapiens (human), Heterogeneous nuclear ribonucleoprotein A1 from Homo sapiens (human), Heterogeneous nuclear...
From €57.50 *
Details
CKS2 11-19 (HLA-C0702)
KYFDEHYEY is a linear peptidic epitope studied as part of Cyclin-dependent kinases regulatory subunit 2 from Homo sapiens (human) and Other Mus musculus (mouse) protein from Mus musculus (mouse). This epitope has been studied for immune...
From €57.50 *
Details
STREP-tag II
NWSHPQFEK is a selected nine-amino acid peptide that displays intrinsic binding affinity towards streptavidin, suitable for use in ELISA and antibody blocking.
From €57.50 *
Details
STREP-tag I
AWRHPQFGG is a selected nine-amino acid peptide that displays intrinsic binding affinity towards streptavidin, it has been used as an affinity tag for recombinant proteins.
From €57.50 *
Details
NRP-A7 (H-2Kd)
KYNKANAFL is a linear peptidic epitope. This epitope has been studied for immune reactivity in, tested in T cell assays and MHC ligand assays.
From €57.50 *
Details
NRP-V7 (H-2Kd)
NRP-V7 is a H-2Kd-restricted epitope that is recognized by T-cell receptors expressed by CD8 cells.
From €57.50 *
Details
WT1 126-134 mutant (HLA-A*02:01) 126Y
Wilms tumor protein is a protein that is encoded by the WT1 gene on chromosome 11p in humans. WT1 is a tumour suppressor gene associated with the development of Wilms' Tumour, from which it was named. Mutations in exon 7 and 9 of WT1...
From €57.50 *
Details
Human adenovirus 5 542-550 (HLA-A*02:02)
#
From €57.50 *
Details
HDV 194-202
FPWDILFPA is a linear peptidic epitope studied as part of Large delta antigen from Hepatitis delta virus, tested in T cell assays and MHC ligand assays.
From €57.50 *
Details
HDV 192-200
QGFPWDILF is a linear peptidic epitope studied as part of Large delta antigen from Hepatitis delta virus, tested in T cell assays and MHC ligand assays
From €57.50 *
Details
NS3 73-81 (HLA-B*15:01)
#
From €57.50 *
Details
NS5 465-479
#
From €115.00 *
Details
NS4b 77-91
#
From €115.00 *
Details
Env 345-359
#
From €149.50 *
Details
Env 57-71
#
From €149.50 *
Details
RSV Fusion glycoprotein F0 precursor 542-550...
#
From €57.50 *
Details
RSV MP2 64-72 (HLA-B44)
#
From €57.50 *
Details
RSV Fusion glycoprotein F0 precursor 106-114...
#
From €57.50 *
Details
RSV NP 255-263 (HLA-B*08:01)
#
From €57.50 *
Details
RSV NP 306-314 (HLA-B*07:02)
#
From €57.50 *
Details
RSV MP2 151-159 (HLA-A*03:01)
#
From €57.50 *
Details
RSV Fusion protein 250-258 (HLA-A*02:01)
#
From €57.50 *
Details
RSV Fusion protein 451-459 (HLA-A*02:01)
#
From €57.50 *
Details
RSV Fusion protein 173-181 (HLA-A*02:01)
#
From €57.50 *
Details
RSV Fusion protein 180-188 (HLA-A*02:01)
#
From €57.50 *
Details
RSV NP 16-24 (HLA-A*02:01)
#
From €57.50 *
Details
RSV Fusion protein 273-281 (HLA-A*02:01)
#
From €57.50 *
Details
RSV Fusion protein 171-179 (HLA-A*02:01)
#
From €57.50 *
Details
RSV Fusion protein 538-546 (HLA-A*02:01)
#
From €57.50 *
Details
RSV Fusion protein 191-199 (HLA-A*02:01)
#
From €57.50 *
Details
RSV Fusion protein 272-280 (HLA-A*02:01)
#
From €57.50 *
Details
RSV Fusion protein 498-506 (HLA-A*02:01)
#
From €57.50 *
Details
RSV Fusion protein 394-402 (HLA-A*02:01)
#
From €57.50 *
Details
RSV Fusion protein 159-167 (HLA-A*02:01)
#
From €57.50 *
Details
RSV Fusion protein 114-122 (HLA-A*02:01)
#
From €57.50 *
Details
RSV Fusion protein 140-148 (HLA-A*02:01)
#
From €57.50 *
Details
RSV Fusion protein 82-90 (HLA-A*02:01)
#
From €57.50 *
Details
RSV Fusion protein 170-178 (HLA-A*02:01)
#
From €57.50 *
Details
RSV Fusion protein 10-18 (HLA-A*02:01)
#
From €57.50 *
Details
HPV E6 52-61 (HLA-B*35:01)
FAFRDLCIVY is a linear peptidic epitope studied as part of Protein E6 from Alphapapillomavirus 9. This epitope has been studied for immune reactivity, tested in T cell assays.
From €57.50 *
Details
HPV L1 296-304 (HLA-A*11)
AVPDDLYIK is a linear peptidic epitope studied as part of Major capsid protein L1 from Alphapapillomavirus 9, tested in T cell assays and MHC ligand assay.
From €57.50 *
Details
HPV E6 75-83 (HLA-A*24:02)
EYRHYCYSL is a linear peptidic epitope studied as part of Protein E6 from Alphapapillomavirus 9. This epitope has been studied for immune reactivity, tested in T cell assays, B cell assay and MHC ligand assays.
From €57.50 *
Details
HPV E6 87-95 (HLA-A*24:01)
CYSLYGTTL is a linear peptidic epitope studied as part of Protein E6 from Alphapapillomavirus 9. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays.
From €57.50 *
Details
HPV16 L1 349-357 (HLA-A*02:01)
ICWGNQLFV is a linear peptidic epitope studied as part of Major capsid protein L1 from Alphapapillomavirus 9, tested in 2 T cell assays.
From €57.50 *
Details
HPV 16 E2 69–77 (HLA-A*02:01)
ALQAIELQL is a linear peptidic epitope studied as part of Regulatory protein E2 from Alphapapillomavirus 9. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays.
From €57.50 *
Details
HPV E7 81-89 (HLA-A*02:01)
DLLLGTLNI is a linear peptidic epitope studied as part of Protein E7 from Alphapapillomavirus 10. This epitope has been studied for immune reactivity, tested in T cell assays.
From €57.50 *
Details
PSMA 624-632 (HLA-A*24:02)
#
From €57.50 *
Details
PSMA 178-186 (HLA-A*24:02)
#
From €57.50 *
Details
PSMA 227-235 (HLA-A*24:02)
#
From €57.50 *
Details
PSMA 441-450 (HLA-A*02:01)
#
From €57.50 *
Details
BCR-ABL 926-934 (HLA-A*02:01)
This peptide is a tetramer of biotinylated peptide with streptavidin mainly composed of human ABL1 of peptide GFKQSSKAL covering 19-27 and B*27:01 molecule. The pMHC tetramer recognizes CD8 T cells, and can be used in the analysis of...
From €57.50 *
Details
Survivin 53-62 (HLA-A*11:01)
#
From €57.50 *
Details
Survivin 47-56 (Y10) (HLA-A*01:01)
#
From €57.50 *
Details
PSA 248-257 (HLA-A*24:02)
#
From €57.50 *
Details
PSA 68-77b (HLA-A*01:01)
#
From €57.50 *
Details
TRP2 181-190 (HLA-A*01:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed TRP-2-derived peptide of VYDFFVWLHY sequence covering 181-190 and...
From €57.50 *
Details
MAGE-C2 191-200 (HLA-A*2)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed MAGEC2-derived peptide of LLFGLALIEV sequence covering 191-200...
From €57.50 *
Details
MG50 210-218 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed MG50-derived peptide of TLHCDCEIL sequence covering 210-218 and...
From €57.50 *
Details
MOG 37-50
Myelin oligodendrocyte glycoprotein (MOG)37-50, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
Influenza NP 147-155 (H-2Kd)
TYQRTRALV is a linear peptidic epitope studied as part of Nucleoprotein from Influenza A virus. This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays, MHC ligand assays
From €57.50 *
Details
Influenza NP 55-63 (HLA-A*02:01)
#
From €57.50 *
Details